Patient Perspectives on Factors Affecting Direct Oral Anticoagulant Use for Stroke Prevention in Atrial Fibrillation

References

• Chugh SS, Havmoeller R, Narayanan K, et al. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 study. Circulation. 2014;129(8):837–847. doi:10.1161/CIRCULATIONAHA.113.005119
   PubMed Web of Science ®Google Scholar
• Lippi G, Sanchis-Gomar F, Cervellin G. Global epidemiology of atrial fibrillation: an increasing epidemic and public health challenge. Int J Stroke. 2020;1–5. doi:10.1177/1747493019897870
   Web of Science ®Google Scholar
• Friberg L, Rosenqvist M, Lindgren A, et al. High prevalence of atrial fibrillation among patients with ischemic stroke. Stroke. 2014;45:2599–2605. doi:10.1161/STROKEAHA.114.006070
   PubMed Web of Science ®Google Scholar
• The National Institute for Health Care and Excellence (NICE). Atrial fibrillation: management (CG180); 2020. Available from: https://www.nice.org.uk/guidance/cg180. Accessed May 26, 2020.
   Google Scholar
• Cowan JC, Wu J, Hall M, et al. A 10-year study of hospitalized atrial fibrillation-related stroke in England and its association with uptake of oral anticoagulants. Eur Heart J. 2018;39(32):2975–2983. doi:10.1093/eurheartj/ehy411
   PubMed Web of Science ®Google Scholar
• Kirchhof P, Benussi S, Kotecha D, et al. ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37:2893–2962.
   PubMed Web of Science ®Google Scholar
• The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Guidelines for the management of atrial fibrillation. Eur Heart J. 2011;6:240–429.
   Google Scholar
• The Task Force for the management of atrial fibrillation of the European Society of Cardiology (ESC). ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37:2893–2962.
   Web of Science ®Google Scholar
• Bai Y, Guo SD, Deng H, et al. Effectiveness and safety of oral anticoagulants in older patients with atrial fibrillation: a systematic review and meta-regression analysis. Age Ageing. 2018;47(1):9–17. doi:10.1093/ageing/afx103
   PubMed Web of Science ®Google Scholar
• Loo SY, Dell’Aniello S, Huiart L, et al. Trends in the prescription of novel oral anticoagulants in UK primary care. Br J Clin Pharmacol. 2017;83(9):2096–2106. doi:10.1111/bcp.13299
   PubMed Web of Science ®Google Scholar
• ABPI SAFI. One year on: why patients still having unnecessary AF-related strokes? 2016. Available from: http://www.abpi.org.uk/mediacentre/newsreleases/2016/Documents/Embargo9May_ABPI_OneYearOn_FINALREPORT.pdf. Accessed February 17, 2017.
   Google Scholar
• AbuDagga A, Stephenson JJ, Fu AC, et al. Characteristics affecting oral anticoagulant therapy choice among patients with non-valvular atrial fibrillation: a retrospective claims analysis. BMC Health Serv Res. 2014;14:310. doi:10.1186/1472-6963-14-310
   PubMed Web of Science ®Google Scholar
• Baik SH, Hernandez I, Zhang Y. Evaluating the initiation of novel oral anticoagulants in medicare beneficiaries. J Manag Care Spec Pharm. 2016;22(3):281‐292. doi:10.18553/jmcp.2016.22.3.281
   Google Scholar
• Huang C, Siu M, Vu L, et al. Factors influencing doctors’ selection of dabigatran in non-valvular atrial fibrillation. J Eval Clin Pract. 2013;19:938–943. doi:10.1111/j.1365-2753.2012.01886.x
   PubMed Web of Science ®Google Scholar
• Patel PA, Zhao X, Fonarow GC, et al. Novel oral anticoagulant use among patients with atrial fibrillation hospitalized with ischemic stroke or transient ischemic attack. Circ Cardiovasc Qual Outcomes. 2015;8(4):383–392. doi:10.1161/CIRCOUTCOMES.114.000907
   PubMed Web of Science ®Google Scholar
• Potpara TS, Trendafilova E, Dan GA, et al. The patterns of Non-vitamin K Antagonist Oral Anticoagulants (NOACs) use in patients with atrial fibrillation in seven Balkan countries: a report from the BALKAN-AF survey. Adv Ther. 2017;34:2043–2057. doi:10.1007/s12325-017-0589-5
   PubMed Web of Science ®Google Scholar
• Salmasi S, Kapanen AI, Kwan L, et al. Atrial fibrillation patients’ experiences and perspectives of anticoagulation therapy changes. Res Social Adm Pharm. 2020;16(10):1409–1415. doi:10.1016/j.sapharm.2020.01.004
   Web of Science ®Google Scholar
• Anderson TS, Lo-Ciganic WH, Gellad WF, et al. Patterns and predictors of physician adoption of new cardiovascular drugs. Healthcare. 2018;6:33–40. doi:10.1016/j.hjdsi.2017.09.004
   Web of Science ®Google Scholar
• Brais C, Larochelle J, Turgeon MH, et al. Predictors of direct oral anticoagulants utilization for thromboembolism prevention in atrial fibrillation. J Pharm Pharm. 2017;20:8–14.
   Google Scholar
• Zhang Y, Méndez SJ, Scott A. Factors affecting general practitioners’ decisions to adopt new prescription drugs – cohort analyses using Australian longitudinal physician survey data. BMC Health Serv Res. 2019;19(1):94. doi:10.1186/s12913-019-3889-4
   PubMed Web of Science ®Google Scholar
• Clarkesmith DE, Lip GHY, Lane DA. Patients’ experiences of atrial fibrillation and non-vitamin K antagonist oral anticoagulants (NOACs), and their educational needs: a qualitative study. Thromb Res. 2017;153:19–27. doi:10.1016/j.thromres.2017.03.002
   Web of Science ®Google Scholar
• Murphy A, Kirby A, Bradley C. Knowledge is power: general practitioners prescribing of new oral anticoagulants in Ireland. BMC Res Notes. 2018;11:478–484. doi:10.1186/s13104-018-3597-x
   Google Scholar
• Tanislav C, Allendorfer J, Pfeilschifter W, et al. One decade of oral anticoagulation in stroke patients: results from a large country-wide hospital-based registry. Int J Stroke. 2018;13(3):308–312. doi:10.1177/1747493017733928
   Web of Science ®Google Scholar
• Lo-Ciganic WH, Gellad WF, Huskamp HA, et al. Who were the early adopters of dabigatran? An application of group-based trajectory models. Med Care. 2016;54(7):725–732. doi:10.1097/MLR.0000000000000549
   Web of Science ®Google Scholar
• Medlinskiene K, Tomlinson J, Marques I, et al. Barriers and Facilitators to Implementation of New Medicines into Clinical: A Systematic Review. Bradford: University of Bradford; 2020.
   Google Scholar
• Department of Health. The NHS Constitution: the NHS belongs to us all; 2015. Available from: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/480482/NNH_Constitution_WEB.pdf. Accessed March 17, 2017.
   Google Scholar
• Loughlin M, Buetow S, Cournoyea M, et al. Interactions between persons—knowledge, decision making, and the co‐production of practice. J Eval Clin Pract. 2019;25:911–920. doi:10.1111/jep.13297
   Web of Science ®Google Scholar
• Borg CX, Shaw R, Lane DA. Patients’ and health professionals’ views and experiences of atrial fibrillation and oral-anticoagulation therapy: a qualitative meta-synthesis. Patient Educ Couns. 2012;88(2):330–337. doi:10.1016/j.pec.2012.05.011
   Web of Science ®Google Scholar
• Medlinskiene K, Petty D, Richardson S, et al. Are patients with non-valvular atrial fibrillation involved in decision-making about oral anticoagulants? A literature review. IJPP. 2018;26(1 Suppl):S42–S43.
   Google Scholar
• Choi JC, DiBonaventura M, Kopenhafer L, et al. Survey of the use of warfarin and the newer anticoagulant dabigatran in patients with atrial fibrillation. Patient Prefer Adherence. 2014;8:167–177. doi:10.2147/PPA.S56187
   PubMed Web of Science ®Google Scholar
• Tomlinson J, Medlinskiene K, Cheong V, et al. Patient and public involvement in designing and conducting doctoral research: the whys and the hows. Res Involv Engagem. 2019;5(23). doi:10.1186/s40900-019-0155-1
   Google Scholar
• Coyne IT. Sampling in qualitative research. Purposeful and theoretical sampling; merging or clear boundaries? J Adv Nurs. 1997;26(3):623–630. doi:10.1046/j.1365-2648.1997.t01-25-00999.x
   PubMed Web of Science ®Google Scholar
• Patton MQ. Qualitative Research and Evaluation Methods. London: SAGE publications; 2015.
   Google Scholar
• Dantas GC, Thompson BV, Manson JA, et al. Patients’ perspectives on taking warfarin: qualitative study in family practice. BMC Fam Pract. 2004;5:15–24. doi:10.1186/1471-2296-5-15
   PubMedGoogle Scholar
• Borg XC, Shaw RL, Lane DA. Patients’ and physicians’ experiences of atrial fibrillation consultations and anticoagulation decision-making: a multi-perspective IPA design. Psychol Health. 2016;31(4):436–455. doi:10.1080/08870446.2015.1116534
   Web of Science ®Google Scholar
• Guest G, Bunce A, Johnson L. How many interviews are enough? An experiment with data saturation and variability. Field Methods. 2006;18(1):59–82. doi:10.1177/1525822X05279903
   Web of Science ®Google Scholar
• Ritchie J, Lewis J, Nicholls C, et al. Qualitative Research Practice: A Guide for Social Science Students and Researchers. London: SAGE publications; 2014.
   Google Scholar
• Gale NK, Heath G, Cameron E, et al. Using the framework method for the analysis of qualitative data in multi-disciplinary health research. BMC Medical Research Methodology. 2013;13(1):117–125. doi:10.1186/1471-2288-13-117
   PubMed Web of Science ®Google Scholar
• Parkinson S, Eatough V, Holmes J, et al. Framework analysis: a worked example of a study exploring young people’s experiences of depression. Qual Res Psychol. 2016;13(2):109–129. doi:10.1080/14780887.2015.1119228
   Web of Science ®Google Scholar
• Nowell LS, Norris JM, White DE, et al. Thematic analysis: striving to meet the trustworthiness criteria. Int J Qual Methods. 2017;16(1):1–13. doi:10.1177/1609406917733847
   Web of Science ®Google Scholar
• Pritchett RV, Clarke JL, Jolly K, et al. Clinicians’ views and experiences of prescribing oral anticoagulants for stroke prevention in atrial fibrillation: a qualitative meta-synthesis. PLoS One. 2020;15(5):e0232484. doi:10.1371/journal.pone.0232484
   Web of Science ®Google Scholar
• Beyene K, Chan AHY, Bandreddi NST, et al. Patient satisfaction with community pharmacist-led anticoagulation management services and its relationship with patient characteristics in New Zealand. Int J Clin Pharm. 2020. doi:10.1007/s11096-020-01124-y
   Web of Science ®Google Scholar
• Ingram SJ, Kirkdale CL, Williams S, et al. Moving anticoagulation initiation and monitoring services into the community: evaluation of the Brighton and Hove community pharmacy service. BMC Health Serv Res. 2018;18(1):91. doi:10.1186/s12913-018-2901-8
   PubMed Web of Science ®Google Scholar
• Kirley K, Goutham R, Bauer V, et al. The role of NOACs in atrial fibrillation management: a qualitative study. J Atr Fibrillation. 2016;9(1):1416. doi:10.4022/jafib.1416
   PubMedGoogle Scholar
• Andrade JG, Krahn AD, Skanes AC, et al. Value and preferences of physicians and patients with nonvalvular atrial fibrillation who receive oral anticoagulation therapy for stroke prevention. Can J Cardiol. 2017;32:747–753. doi:10.1016/j.cjca.2015.09.023
   Web of Science ®Google Scholar
• Baicus C, Balanescu P, Zeh S, et al. Characteristics of shared decision making in Romania from the patient perspective: a cross‐sectional multicentric study. J Eval Clin. 2019;25:1152–1159. doi:10.1111/jep.13257
   Web of Science ®Google Scholar
• Shay LA, Lafata JE. Where is the evidence? A systematic review of shared decision making and patient outcomes. Med Decis Making. 2015;35(1):114–131. doi:10.1177/0272989X14551638
   PubMed Web of Science ®Google Scholar